Luminex Corporation develops, manufactures & markets biological testing technologies in the clinical diagnostic and life science industries.

We would like to show you a description here but the site won’t allow us.

Certain applications of Luminex products, may be covered by patents owned by parties other than Luminex. Purchase of Luminex products does not convey a license to any third party patents unless explicitly stated in writing.

Created Date: 4/8/2015 4:24:46 PM

ausagileprod.luminexcorp.com:7001

Luminex designed the combined assay to quickly deliver clear answers about these infections from a single test and, thereby, help clinical-care teams treat patients more effectively. The ARIES ® Flu A/B & RSV+SARS-CoV-2 Assay can be run on six-unit and 12-unit ARIES ® Systems with minimal hands-on time, producing results in approximately two ...

Add to favourite0 Version 38 Download 1.96 MB File Size 1 File Count April 25, 2019 Create Date January 6, 2022 Last Updated Download File Action 026-00098-01.pdf ...

AUSTIN, Texas, Jan. 12, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced 4 th quarter 2020 revenue of approximately $111M, up approximately 23% over the 4 th quarter of 2019 and full-year revenue of approximately $417M, up approximately 25% over the full year 2019. Fourth quarter and full year highlights include:

AUSTIN, Texas, June 13, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced the company recently began clinical studies for the Gastrointestinal (GI) Assay on the VERIGENE® II System, its new sample to answer benchtop molecular diagnostic system in …

MultiCode EBV Primers Certificate of Conformance, Lot Number 3519542. 48.51 KB 385 downloads . Installation Instructions, SYNCT 1.1u2 Software, Spanish-Spain